Format

Send to

Choose Destination
Vaccine. 2003 May 1;21(16):1789-95.

Novel generations of influenza vaccines.

Author information

1
MedImmune Vaccines, 297 North Bernardo Avenue, Mountain View, CA 94043, USA. kembleg@medimmune.com

Abstract

Several strategies are being pursued to increase the quality and quantity of influenza vaccines that are used on an annual basis including increasing the immunogenicity of currently licensed inactivated vaccines, delivery of inactive vaccines directly to the nasal mucosa, the use of cell lines for virus production and the use of live, attenuated vaccines. In addition, modern molecular biological techniques are being used to create and evaluate new vaccine approaches. This report will briefly review these different strategies and outline some of the potential advantages and challenges associated with them.

PMID:
12686096
DOI:
10.1016/s0264-410x(03)00074-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center